Resumen de Impacto de un programa de validación transversal en atención farmacéutica al paciente con insuficiencia renal
Marta Gallego Úbeda, Federico Tutau Gómez, Laura Delgado Téllez, María Angeles Campos Fernández de Sevilla
Objective: Description of pharmaceutical interventions performed on patients with kidney failure (KF) according to the cross-sectional validation (CV) methodology, and by means of a new computer software tool. Method: 7-month observational study in hospitalization and emergency services. We proposed CV as a complement to the traditional pharmacotherapeutic validation. For such a purpose, we designed a software tool that: 1. Integrates the hospital's computer systems; 2. Reports those patients with ClCr (Creatinine Clearance) <60 ml/min/1.73 m 2 and drugs that require a recommendation on KF; and 3. Sends those recommendations to the physician. Results: 2,535 patients showed a ClCr < 60 ml/min/1.73 m 2, 806 of them also had some drugs that required recommendation on KF. 295 interventions were performed: 48% accepted and 19% rejected (the remaining were classified as "not applicable"). The active principle and department with the most interventions were respectively levofloxacin and the Emergency Department. A pharmacist performed, on an average time of 26.7 minutes/day, the CV of the KF DRP (Drug Related Problem) in all patients. Conclusions: CV increases the efficiency in detecting and resolving DRPs, allows for an early detection in the Emergency Department and helps in the decision-making process
